- Posts by Cara S. DonelsSenior Associate
Cara has experience representing and advising clients in many industries, including medical and mechanical device manufacturers and pharmaceutical researchers. Cara’s practice spans the country and includes appearances in ...
The U.S. Supreme Court recently issued its decision in Amgen Inc. v. Sanofi; a decision long-awaited by patent practitioners. In its decision, the Court unanimously held that several of Amgen’s patent claims to a class of antibodies were invalid for lack of enablement.
- EventPreparing for Immigration Policy Changes and the H-1B Lottery Under the Second Trump Administration
- EventEnforceable Business Protection Agreements: Making Sure Your Restrictive Covenants Are Worth the Paper They’re Written On
- EventHealthcare and FDA Compliance in 2025: Litigation Insights & Real-World Strategies
- EventHealth Law Webinar – The Most Common Questions and Misconceptions About Audits and Reviews